Parsons, Mark W., Christensen, Soren, Davis, Stephen M., McElduff, Patrick, Levi, Christopher R., Butcher, Ken S., De Silva, Deidre A., Ebinger, Martin, Barber, P. Alan, Bladin, Christopher, Donnan, Geoffrey A.. Nature Publishing Group; 2010. Pretreatment diffusion - and perfusion - MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis.

Sarraj, Amrou, Parsons, Mark, Bivard, Andrew, Hassan, Ameer E., Abraham, Michael G., Wu, Teddy, Kleinig, Timothy, Lin, Longting, Chen, Chushuang, Levi, Christopher, Dong, Qiang, Cheng, Xin, Butcher, Ken S., Choi, Philip, Yassi, Nawaf, Shah, Darshan, Sharma, Gagan, Pujara, Deep, Shaker, Faris, Blackburn, Spiros. John Wiley & Sons; 2022. Endovascular Thrombectomy Versus Medical Management in Isolated M2 Occlusions: Pooled Patient-Level Analysis from the EXTEND-IA Trials, INSPIRE, and SELECT Studies.

Arora, Kshitij, Gaekwad, Aaron, Spratt, Neil J., Parsons, Mark W., Butcher, Ken S., Evans, James, O'Brien, William, Ang, Timothy, Garcia-Esperon, Carlos, Blair, Christopher, Edwards, Leon S., Chew, Beng L. A., Delcourt, Candice. Lippincott Williams & Wilkins; 2022. Diagnostic Utility of Computed Tomography Perfusion in the Telestroke Setting.

Subramaniam, Jayden C., Cheung, Andrew, Butcher, Ken S., Manning, Nathan, Whitley, Justin, Cordato, Dennis, Zagami, Alessandro, Cappelen-Smith, Cecilia, Tian, Huiqiao, Levi, Chris, Parsons, Mark. Public Library of Science (PLOS); 2023. Most endovascular thrombectomy patients have Target Mismatch despite absence of formal CT perfusion selection criteria.

Coutts, Shelagh B., Ankolekar, Sandeep, Camden, Marie-Christine, Campbell, Bruce C. V., Casaubon, Leanne K., Catanese, Luciana, Chatterjee, Kausik, Choi, Philip M. C., Clarke, Brian, Dowlatshahi, Dar, Ferrari, Julia, Field, Thalia S., Appireddy, Ramana, Ganesh, Aravind, Ghia, D, Goyal, M, Greisenegger, S, Halse, O, Horn, M, Hunter, G, Imoukhuede, O, Kelly, PJ, Kennedy, J, Arenillas, Juan F., Kenney, C, Kleinig, TJ, Krishnan, K, Lima, F, Mandzia, JL, Marko, M, Martins, SO, Medvedev, G, Menon, BK, Mishra, SM, Assis, Zarina, Molina, C, Moussaddy, A, Muir, KW, Parsons, MW, Penn, AMW, Pille, A, Pontes-Neto, OM, Roffe, C, Serena, J, Simister, R, Bailey, Peter, Singh, N, Spratt, Neil, Strbian, D, Tham, CH, Wiggam, MI, Williams, DJ, Willmot, MR, Wu, T, Yu, AYX, Zachariah, G, Barber, Philip A., Zafar, A, Zerna, C, Hill, MD, Salluzzi, M, Blenkin, N, Dueck, A, Doram, C, Zhang, Q, Ryckborst, K, Bohn, S, Bazan, Rodrigo, Collier, Q, Taylor, F, Lethebe, BC, Jambula, A, Sage, K, Toussaint, L, Save, S, Lee, J, Laham, N, Sultan, AA, Buck, Brian H., Deepak, A, Sitaram, A, Demchuk, AM, Lockey, A, Micielli, A, Wadhwa, A, Arabambi, B, Graham, B, Bogiatzi, C, Doshi, D, Butcher, Ken S., Chakraborty, D, Kim, D, Vasquez, D, Singh, D, Tse, D, Harrison, E, Smith, EE, Teleg, E, Klourfeld, E, Klein, G. The Lancet Publishing Group; 2024. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.